The Latest Breaking News from diabetes

Akero Therapeutics (NASDAQ:AKRO) revealed topline data from HARMONY, a 24-week Phase 2b study evaluating the efficacy and safety of its lead product candidate efruxifermin (EFX) in patients with pre-cirrhotic nonalcoholic steatohepatitis (NASH), the study met its primary endpoint for both the 50mg and 28mg EFX dose groups. Akero Therapeutics shares…

Globally, it is widely acknowledged that obesity-related conditions and their complications add hugely to healthcare costs and productivity losses. In turn this adds a large burden on individuals, their families and on governments.

People with diabetes may experience damage to the small blood vessels in various organs. The reasons for this are unclear, but it has been known since the 1990s that good control of blood sugar levels reduces the risk of complications. Read more on Dynamite News

The vegetable was shown to lower blood sugar levels and cholesterol levels

The injection contains an appetite suppressing drug called semaglutide, and is being hailed as a 'game changer' by experts in the United States

The vegetable was shown to lower blood sugar levels and cholesterol levels

The vegetable was shown to lower blood sugar levels and cholesterol levels

A Queensland court hears that four of the 14 people charged over Elizabeth Struhs's death did not receive briefs of evidence due to a miscommunication between police and the prison where they are on remand.

Pioneering scheme runs clinics and uses motorcycle taxi network to get insulin and supplies to those in remote areas

The vegetable was shown to lower blood sugar levels and cholesterol levels

With multiple data points, a continuous glucose monitor offers a more complete picture of how your body manages blood sugar but hasn’t replaced finger sticks.